Related Experiment Video

Updated: May 6, 2026

Author Spotlight: Optogenetic Inhibition of Rho1-Mediated Actomyosin Contractility Coupled with Measurement of Epithelial Tension in Drosophila Embryos
12:35

Author Spotlight: Optogenetic Inhibition of Rho1-Mediated Actomyosin Contractility Coupled with Measurement of Epithelial Tension in Drosophila Embryos

Published on: April 14, 2023

2.0K

Pharmacological inhibition of actin assembly to target tumor cell motility

Alexander Nürnberg1, Alina Kollmannsperger, Robert Grosse

  • 1Institute of Pharmacology, University of Marburg, Marburg, 35032, Germany, mail@nuernberg.su.

Reviews of Physiology, Biochemistry and Pharmacology
|November 7, 2013
PubMed

Insights

Tumor cell migration, crucial for metastasis, relies on actin cytoskeleton dynamics. New small-molecule inhibitors targeting actin assembly factors offer potential strategies to prevent cancer spread and invasion.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Pharmacology

Background:

  • Tumor metastasis is a major clinical challenge.
  • Tumor cell migration, driven by actin cytoskeleton reorganization, is key to metastasis.
  • Actin assembly factors are emerging as therapeutic targets.

Purpose of the Study:

  • To review newly identified small-molecule inhibitors.
  • To highlight inhibitors targeting actin nucleation and assembly factors.
  • To discuss the relevance of these factors in human disease.

Main Methods:

  • Literature review of recent studies.
  • Focus on small-molecule inhibitors of actin assembly.
  • Analysis of actin nucleation and assembly factors.

Main Results:

  • Several novel small-molecule inhibitors have been identified.
  • These inhibitors target key actin nucleation and assembly factors.
  • Pharmacological modulation of actin assembly can impact tumor invasion.

Conclusions:

  • Small-molecule inhibitors targeting actin assembly factors show promise.
  • These inhibitors represent a potential therapeutic avenue for preventing tumor metastasis.
  • Further research into these inhibitors is warranted for clinical application.

More Related Videos

A Time-Efficient Fluorescence Spectroscopy-Based Assay for Evaluating Actin Polymerization Status in Rodent and Human Brain Tissues06:54

A Time-Efficient Fluorescence Spectroscopy-Based Assay for Evaluating Actin Polymerization Status in Rodent and Human Brain Tissues

Published on: June 3, 2021

3.4K
Aip1p Dynamics Are Altered by the R256H Mutation in Actin08:57

Aip1p Dynamics Are Altered by the R256H Mutation in Actin

Published on: July 30, 2014

7.8K

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Actin Filament Depolymerization01:19

Actin Filament Depolymerization

Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
3.0K
Actin Polymerization and Cell Motility01:13

Actin Polymerization and Cell Motility

Actin is a family of globular proteins that are highly abundant in eukaryotic cells. It makes up approximately 1-5% of total cell protein concentration. Actin monomers polymerize to form a complex network of polarized filaments, the actin cytoskeleton, that plays a crucial role in many cellular processes, including cell motility, division, endocytosis, and metastasis of cancer cells.
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate....
5.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K